ViroGates AS (OCSE:VIRO) Short Interest


OCSE:VIRO ViroGates AS OCSE:VIRO
44 GF Score
Price kr10.20
GF Value kr6.80
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is ViroGates AS Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


OCSE:VIRO vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, ViroGates AS's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ViroGates AS Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ViroGates AS's Short Interest distribution charts can be found below:

* The bar in red indicates where ViroGates AS's Short Interest falls into.


OCSE:VIRO
44GF Score
ViroGates AS OCSE:VIRO
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ViroGates AS (OCSE:VIRO) Overvalued in 2026?

Based on GuruFocus' analysis, ViroGates AS stock appears to be overvalued. The current stock price of kr10.20 is trading 50% above its estimated GF Value™ of kr6.80. GuruFocus considers ViroGates AS to be Significantly Overvalued.

Key valuation signals for OCSE:VIRO:

  • Short Interest:
  • GF Value™: kr6.80 vs. price of kr10.20 (50% above fair value)
  • GF Score™: 44/100 with 2 warning signs

No single metric tells the full story. See the OCSE:VIRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ViroGates AS Business Description

Address Banevaenget 13, Birkerod, DNK, 3460
ViroGates AS is an international medical technology company that develops and markets blood tests to measure chronic inflammation at health clinics and hospitals. The company markets its blood test products under the suPARnostic brand. Its product portfolio comprises suPARnostic TurbiLatex, suPARnostic Quick Triage, and suPARnostic Auto Flex ELISA kit. These products are mainly used to measure the suPAR (soluble urokinase Plasminogen Activator Receptor) protein in the bloodstream.
44GF Score

Get the complete analysis for OCSE:VIRO

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr10.20
Price
kr6.80
GF Value